These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 21364499

  • 1. Sirolimus and proteinuria in renal transplant patients: evidence for a dose-dependent effect on slit diaphragm-associated proteins.
    Stallone G, Infante B, Pontrelli P, Gigante M, Montemurno E, Loverre A, Rossini M, Schena FP, Grandaliano G, Gesualdo L.
    Transplantation; 2011 May 15; 91(9):997-1004. PubMed ID: 21364499
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. mTOR regulates expression of slit diaphragm proteins and cytoskeleton structure in podocytes.
    Vollenbröker B, George B, Wolfgart M, Saleem MA, Pavenstädt H, Weide T.
    Am J Physiol Renal Physiol; 2009 Feb 15; 296(2):F418-26. PubMed ID: 19019920
    [Abstract] [Full Text] [Related]

  • 5. Sirolimus damages podocytes in rats with protein overload nephropathy.
    Cai Y, Chen Y, Zheng S, Chen B, Yang Y, Xia P.
    J Nephrol; 2011 Feb 15; 24(3):307-12. PubMed ID: 20954132
    [Abstract] [Full Text] [Related]

  • 6. Factors associated with proteinuria in renal transplant recipients treated with sirolimus.
    Liew A, Chiang GS, Vathsala A.
    Transpl Int; 2009 Mar 15; 22(3):313-22. PubMed ID: 19054382
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Minimize kidney failure in transplantation patients with proliferation signal inhibitors].
    Glowacki F, Dharancy S, Noël C, Hazzan M.
    Gastroenterol Clin Biol; 2009 Nov 15; 33 Suppl 4():S253-6. PubMed ID: 20004331
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Proteinuria in transplant patients associated with sirolimus.
    Franco AF, Martini D, Abensur H, Noronha IL.
    Transplant Proc; 2007 Mar 15; 39(2):449-52. PubMed ID: 17362756
    [Abstract] [Full Text] [Related]

  • 15. Proteinuria after conversion to sirolimus in renal transplant recipients.
    Sahin GM, Sahin S, Kantarci G, Ergin H.
    Transplant Proc; 2006 Dec 15; 38(10):3473-5. PubMed ID: 17175308
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Significance and management of proteinuria in kidney transplant recipients.
    Amer H, Cosio FG.
    J Am Soc Nephrol; 2009 Dec 15; 20(12):2490-2. PubMed ID: 19820126
    [Abstract] [Full Text] [Related]

  • 18. Conversion to sirolimus for chronic allograft nephropathy and calcineurin inhibitor toxicity and the adverse effects of sirolimus after conversion.
    Sayin B, Karakayali H, Colak T, Sevmis S, Pehlivan S, Demirhan B, Haberal M.
    Transplant Proc; 2009 Sep 15; 41(7):2789-93. PubMed ID: 19765436
    [Abstract] [Full Text] [Related]

  • 19. Proteinuria after conversion to sirolimus in kidney transplant recipients: impact of pre-existing proteinuria, graft function, and angiotensin-converting enzyme inhibitors/angiotensin-receptor antagonists.
    Marx C, Busch M, Ott U, Gerth J, Wolf G.
    Clin Transplant; 2010 Sep 15; 24(5):626-30. PubMed ID: 19925471
    [Abstract] [Full Text] [Related]

  • 20. Clinical implications of proteinuria in renal transplant recipients switching to rapamycin for chronic allograft dysfunction.
    Gutiérrez MJ, González E, Andrés A, Morales JM.
    Transplant Proc; 2009 Sep 15; 41(6):2348-50. PubMed ID: 19715916
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.